Drug Profile
Research programme: inflammasome dysregulation inhibitor - TherimuneX
Alternative Names: NaclynamideLatest Information Update: 25 Apr 2023
Price :
$50
*
At a glance
- Originator Therimunex
- Class Peptide hormones
- Mechanism of Action Caspase 1 inhibitors; Regulatory factor X transcription factor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Bacterial infections; Cancer; Diffuse scleroderma; Idiopathic pulmonary fibrosis
Most Recent Events
- 25 Apr 2023 Discontinued - Preclinical for Alzheimer's disease in USA (Parenteral)
- 25 Apr 2023 Discontinued - Preclinical for Bacterial infections in USA (Parenteral)
- 25 Apr 2023 Discontinued - Preclinical for Cancer in USA (Parenteral)